WFM
CELG

Wilmington Funds Management’s Celgene Corp CELG Stock Holding History

Wilmington Funds Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$2.23M Buy
25,966
+6,310
+32% +$480K 0.23% 125
2014
Q1 		$1.37M Sell
19,656
-8,196
-29% -$649K 0.15% 157
2013
Q4 		$2.35M Sell
27,852
-5,044
-15% -$399K 0.23% 123
2013
Q3 		$2.53M Sell
32,896
-2,200
-6% -$154K 0.24% 137
2013
Q2 		$2.05M Buy
+35,096
New +$2.11M 0.19% 150

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wilmington Funds Management's CELG Position: Q2 2014 in Review

Wilmington Funds Management increased its Celgene Corp (CELG) stake by 32% in Q2 2014, buying an estimated $480K and bringing the position to 25,966 shares worth $2.23M. The position accounts for 0.23% of the portfolio, ranked #125.

Wilmington Funds Management first reported a position in CELG in Q2 2013 and has held it in 5 quarters since. The position peaked at $2.53M in Q3 2013. 995 funds tracked by Wall St. Rank hold CELG as of Q2 2014.

  • Wilmington Funds Management held 25,966 shares of Celgene Corp worth $2.23M as of Q2 2014.
  • Wilmington Funds Management bought 6,310 Celgene Corp shares in Q2 2014, an estimated $480K.
  • Celgene Corp made up 0.23% of Wilmington Funds Management's portfolio in Q2 2014, its #125 holding.
  • Wilmington Funds Management first reported a position in Celgene Corp in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Funds Management's Celgene Corp position peaked at $2.53M in Q3 2013.
  • 995 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.